|

FDA-approved gadolinium-based intravenous contrast agent Clinical Trials

1 actively recruiting trial across 1 location

Also known as: gadobenate dimuglumine, gadopiclenol

Madison, Wisconsin1 trial

Study of 18F-FFNP Breast PET/MRI

UW Carbone Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.